Related Experiment Video
Updated: Jun 30, 2026

Determination of 45 Pesticides in Avocado Varieties by the QuEChERS Method and Gas Chromatography-Tandem Mass Spectrometry
Published on: December 8, 2023
The Food Safety Commission of Japan assessed oxolinic acid, finding adverse effects on body weight and neurological symptoms. An acute reference dose (ARfD) was established at 0.06 mg/kg bw for consumer safety.
Area of Science:
- Food safety
- Toxicology
- Risk assessment
Background:
- Oxolinic acid is an antimicrobial agent with a quinoline structure.
- The Food Safety Commission of Japan (FSCJ) conducted a risk assessment based on submitted documents and additional residue data.
Purpose of the Study:
- To conduct a comprehensive risk assessment of oxolinic acid.
- To evaluate potential adverse effects and establish safety guidelines.
Main Methods:
- Review of submitted data including animal and plant fate, residue data, and various toxicity studies (subacute, chronic, reproductive, developmental, genotoxicity).
- Identification of the lowest observed adverse effect level (NOAEL) from acute neurotoxicity studies in rats.
Main Results:
- Major adverse effects included suppressed body weight gain, testicular interstitial cell hyperplasia, ovarian organ weight increase, neurological symptoms, and behavioral changes.
- No adverse effects were noted for fertility, teratogenicity, or genotoxicity.
- The lowest NOAEL was determined to be 6 mg/kg bw.
Conclusions:
- An acute reference dose (ARfD) of 0.06 mg/kg bw was established by applying a safety factor of 100 to the NOAEL.
- The assessment provides crucial data for ensuring the safe use of oxolinic acid.
Related Concept Videos
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Anthelminthic Agents
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...
Direct-Acting Cholinergic Agonists: Therapeutic Uses

